Clinical Trial Update: Modulation of Circulating Levels of the Ketone Body 3-hydroxybutyrate in Patients With Chronic Heart Failure: Cardiovascular Effects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring modulation of circulating 3-hydroxybutyrate levels in chronic heart failure to assess cardiovascular effects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: University of Aarhus | Conditions: Heart Failure, Ketosis | Phase 2 | Status: UNKNOWN